PM-Scl antibodies are found in patients with homogenous overlap connective tissue disease characterized by Raynaud’s phenomenon, scleroderma, myositis, arthritis and pulmonary restriction. The presence of PM-Scl autoantibodies is a good prognostic sign unlike the poor prognosis seen with other myositis and systemic sclerosis-specific antibodies.
3 - 5 days
- Polymyositis Associated Antibody
- PM-1 Antibody
- Anti-PM/Scl Ab
Test sent to Labcorp Dublin; performed by Esoterix Endocrinology